Objectives To examine the accuracy and impact of artificial intelligence (AI) software assistance in lung cancer screening using CT. Methods A systematic review of CE-marked, AI-based software for ...
Harbor Capital Advisors disclosed the sale of over 300,000 shares of RadNet (RDNT +0.21%) in Q3 2025. The trade was worth an estimated $19.74 million. What happened. According to ...
Before this past fall, if you lived close to the Bemidji area and your doctor recommended a PET/CT scan, it was a bit of a challenge to get that done. “Historically, we’ve had a mobile PET/CT that ...
The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, new research presented at the 38th Annual Congress of the European Association of Nuclear ...
From sagging jowls and sulfurous burps to deflated breasts and surprise pregnancies, the side effects of GLP-1 weight-loss drugs have ranged from subtle to strange. Now, new research suggests that ...
The rise of GLP-1 receptor agonist drugs prescribed for weight loss and type 2 diabetes could be compromising the interpretation of some cancer scans and throwing doctors off course. This is the ...
The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of ...
(Barcelona, Spain, Wednesday 8 September 2025) The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual ...
Cardiac allograft vasculopathy (CAV) is the primary cause of limited long‐term survival among heart transplant recipients. This study aimed to evaluate the feasibility of 18 F‐FAPI‐74 positron ...
About 40% of cancers among Americans can be attributed to potentially modifiable factors such as smoking, drinking, obesity, and physical inactivity. If a widely reported study from earlier this year ...
Detailed price information for Algernon Health Inc (AGNPF) from The Globe and Mail including charting and trades.